Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Low-temperature catalyst based Hydrothermal liquefaction of harmful Macroalgal blooms, and aqueous phase nutrient recycling by microalgae.

Kumar V, Kumar S, Chauhan PK, Verma M, Bahuguna V, Joshi HC, Ahmad W, Negi P, Sharma N, Ramola B, Rautela I, Nanda M, Vlaskin MS.

Sci Rep. 2019 Aug 6;9(1):11384. doi: 10.1038/s41598-019-47664-w.

3.

Spectroscopic investigation of molecular formation in laterally colliding laser-produced carbon plasmas: publisher's note.

Kumar Saxena A, Singh RK, Joshi HC, Kumar A.

Appl Opt. 2019 Feb 10;58(5):1296. doi: 10.1364/AO.58.001296.

PMID:
30874003
4.

Spectroscopic investigation of molecular formation in laterally colliding laser-produced carbon plasmas.

Saxena AK, Singh RK, Joshi HC, Kumar A.

Appl Opt. 2019 Jan 20;58(3):561-570. doi: 10.1364/AO.58.000561.

PMID:
30694241
5.

Comment on the article "Investigation of Fluorescence Resonance Energy Transfer between Fluorescein and Rhodamine 6G".

Joshi NK, Pant S, Joshi HC.

Spectrochim Acta A Mol Biomol Spectrosc. 2017 Mar 5;174:348. doi: 10.1016/j.saa.2016.11.023. Epub 2016 Nov 24.

PMID:
28011245
6.

Aqueous phase adsorption of different sized molecules on activated carbon fibers: Effect of textural properties.

Prajapati YN, Bhaduri B, Joshi HC, Srivastava A, Verma N.

Chemosphere. 2016 Jul;155:62-69. doi: 10.1016/j.chemosphere.2016.04.040. Epub 2016 Apr 20.

PMID:
27107386
7.

Synthesis of carbamoylethyl Cassia angustifolia seed gum in an aqueous medium.

Rajput G, Pandey IP, Joshi HC.

Carbohydr Polym. 2016 Jan 20;136:1259-64. doi: 10.1016/j.carbpol.2015.10.044. Epub 2015 Oct 22.

PMID:
26572469
8.

Emission analysis of a laser-produced barium plasma plume.

Singh RK, Joshi HC, Kumar A.

Appl Opt. 2015 Sep 1;54(25):7673-8. doi: 10.1364/AO.54.007673.

PMID:
26368891
9.

Molecular modeling reveals binding interface of γ-tubulin with GCP4 and interactions with noscapinoids.

Suri C, Joshi HC, Naik PK.

Proteins. 2015 May;83(5):827-43. doi: 10.1002/prot.24773. Epub 2015 Feb 28.

PMID:
25662919
10.

Molecular insight into γ-γ tubulin lateral interactions within the γ-tubulin ring complex (γ-TuRC).

Suri C, Hendrickson TW, Joshi HC, Naik PK.

J Comput Aided Mol Des. 2014 Sep;28(9):961-72. doi: 10.1007/s10822-014-9779-2. Epub 2014 Jul 17.

PMID:
25031076
11.

Slow excited state phototautomerization in 3-hydroxyisoquinoline.

Joshi NK, Arora P, Pant S, Joshi HC.

Photochem Photobiol Sci. 2014 Jun;13(6):929-38. doi: 10.1039/c3pp50356a.

PMID:
24727943
12.

Atypical Presentation of Cavernous Sinus Infection with Intracavernous ICA Aneurysm.

Pant B, Joshi HC, Isser DK.

Indian J Otolaryngol Head Neck Surg. 2014 Jan;66(1):118-21. doi: 10.1007/s12070-012-0560-3. Epub 2012 Aug 24.

13.

Synergistic suppression of noscapine and conventional chemotherapeutics on human glioblastoma cell growth.

Qi Q, Liu X, Li S, Joshi HC, Ye K.

Acta Pharmacol Sin. 2013 Jul;34(7):930-8. doi: 10.1038/aps.2013.40. Epub 2013 May 27.

14.

Preparation of surfactant-mediated silver and copper nanoparticles dispersed in hierarchical carbon micro-nanofibers for antibacterial applications.

Singh S, Ashfaq M, Singh RK, Joshi HC, Srivastava A, Sharma A, Verma N.

N Biotechnol. 2013 Sep 25;30(6):656-65. doi: 10.1016/j.nbt.2013.05.002. Epub 2013 May 18.

PMID:
23692978
15.

Photochemistry and excited state prototropic behaviour of 8-amino 2-naphthol.

Gahlaut R, Joshi HC, Joshi NK, Pandey N, Pant S.

Spectrochim Acta A Mol Biomol Spectrosc. 2013 May 15;109:164-72. doi: 10.1016/j.saa.2013.01.091. Epub 2013 Feb 27.

PMID:
23523759
16.

The microtubule binding drug EM011 inhibits the growth of paediatric low grade gliomas.

Ajeawung NF, Joshi HC, Kamnasaran D.

Cancer Lett. 2013 Jul 10;335(1):109-18. doi: 10.1016/j.canlet.2013.02.004. Epub 2013 Feb 9.

PMID:
23402815
17.

In-Vitro and Ex-Vivo Investigations of the Microtubule Binding Drug Targetin on Angiogenesis.

Ajeawung NF, Mononen L, Thorn A, Pin AL, Joshi HC, Huot J, Kamnasaran D.

J Pediatr Oncol. 2013;1:41-47.

18.
19.

Noscapine induced apoptosis via downregulation of survivin in human neuroblastoma cells having wild type or null p53.

Li S, He J, Li S, Cao G, Tang S, Tong Q, Joshi HC.

PLoS One. 2012;7(7):e40076. doi: 10.1371/journal.pone.0040076. Epub 2012 Jul 26.

20.

Steady state and time-resolved fluorescence study of isoquinoline: reinvestigation of excited state proton transfer.

Joshi NK, Joshi HC, Gahlaut R, Tewari N, Rautela R, Pant S.

J Phys Chem A. 2012 Jul 12;116(27):7272-8. doi: 10.1021/jp210516t. Epub 2012 Jun 28.

PMID:
22690918
21.

Fluorescence characteristics of 5-amino salicylic acid: An iodide recognition study.

Arora P, Suyal K, Joshi NK, Joshi HC, Pant S.

Spectrochim Acta A Mol Biomol Spectrosc. 2012 Aug;94:119-25. doi: 10.1016/j.saa.2012.03.056. Epub 2012 Mar 29.

PMID:
22522294
22.

Copper(I) mediated facile synthesis of potent tubulin polymerization inhibitor, 9-amino-α-noscapine from natural α-noscapine.

Manchukonda NK, Sridhar B, Naik PK, Joshi HC, Kantevari S.

Bioorg Med Chem Lett. 2012 Apr 15;22(8):2983-7. doi: 10.1016/j.bmcl.2012.02.033. Epub 2012 Feb 21.

PMID:
22425569
23.

In silico inspired design and synthesis of a novel tubulin-binding anti-cancer drug: folate conjugated noscapine (Targetin).

Naik PK, Lopus M, Aneja R, Vangapandu SN, Joshi HC.

J Comput Aided Mol Des. 2012 Feb;26(2):233-47. doi: 10.1007/s10822-011-9508-z. Epub 2011 Dec 15.

PMID:
22170255
24.

Chemoprevention of familial adenomatous polyposis by bromo-noscapine (EM011) in the Apc(Min/+) mouse model.

Li S, Ghaleb AM, He J, Bughani U, Bialkowska AB, Yang VW, Joshi HC.

Int J Cancer. 2012 Sep 15;131(6):1435-44. doi: 10.1002/ijc.27344. Epub 2012 Feb 9.

25.

Rational design of novel anti-microtubule agent (9-azido-noscapine) from quantitative structure activity relationship (QSAR) evaluation of noscapinoids.

Santoshi S, Naik PK, Joshi HC.

J Biomol Screen. 2011 Oct;16(9):1047-58. doi: 10.1177/1087057111418654.

PMID:
21972248
26.

Rational design, synthesis and biological evaluations of amino-noscapine: a high affinity tubulin-binding noscapinoid.

Naik PK, Chatterji BP, Vangapandu SN, Aneja R, Chandra R, Kanteveri S, Joshi HC.

J Comput Aided Mol Des. 2011 May;25(5):443-54. doi: 10.1007/s10822-011-9430-4. Epub 2011 May 5.

PMID:
21544622
27.

Molecular modelling and competition binding study of Br-noscapine and colchicine provide insight into noscapinoid-tubulin binding site.

Naik PK, Santoshi S, Rai A, Joshi HC.

J Mol Graph Model. 2011 Jun;29(7):947-55. doi: 10.1016/j.jmgm.2011.03.004. Epub 2011 Apr 9. Erratum in: J Mol Graph Model. 2011 Sep;30:198.

28.
29.

Photochemistry of 5-aminoquinoline in protic and aprotic solvents.

Bridhkoti JP, Mishra H, Joshi HC, Pant S.

Spectrochim Acta A Mol Biomol Spectrosc. 2011 Aug;79(3):412-7. doi: 10.1016/j.saa.2011.02.044. Epub 2011 Mar 23.

PMID:
21501968
30.

A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells.

Aneja R, Miyagi T, Karna P, Ezell T, Shukla D, Vij Gupta M, Yates C, Chinni SR, Zhau H, Chung LW, Joshi HC.

Eur J Cancer. 2010 Jun;46(9):1668-78. doi: 10.1016/j.ejca.2010.02.017. Epub 2010 Mar 18.

31.

Abundance of a distinct cluster of telomere t-stumps in advanced breast cancer cell line.

Pai RB, Pai SB, Yang L, Joshi HC.

Oncol Lett. 2010 Mar;1(2):339-343. Epub 2010 Mar 1.

32.

Recent patents reveal microtubules as persistent promising target for novel drug development for cancers.

Bughani U, Li S, Joshi HC.

Recent Pat Antiinfect Drug Discov. 2009 Nov;4(3):164-82. Review.

PMID:
19673697
33.

Non-toxic melanoma therapy by a novel tubulin-binding agent.

Aneja R, Asress S, Dhiman N, Awasthi A, Rida PC, Arora SK, Zhou J, Glass JD, Joshi HC.

Int J Cancer. 2010 Jan 1;126(1):256-65. doi: 10.1002/ijc.24765.

34.

9-bromonoscapine-induced mitotic arrest of cigarette smoke condensate-transformed breast epithelial cells.

Jaiswal AS, Aneja R, Connors SK, Joshi HC, Multani AS, Pathak S, Narayan S.

J Cell Biochem. 2009 Apr 15;106(6):1146-56. doi: 10.1002/jcb.22099.

35.

Parkin regulates Eg5 expression by Hsp70 ubiquitination-dependent inactivation of c-Jun NH2-terminal kinase.

Liu M, Aneja R, Sun X, Xie S, Wang H, Wu X, Dong JT, Li M, Joshi HC, Zhou J.

J Biol Chem. 2008 Dec 19;283(51):35783-8. doi: 10.1074/jbc.M806860200. Epub 2008 Oct 9.

36.

Multidrug resistance-associated protein-overexpressing teniposide-resistant human lymphomas undergo apoptosis by a tubulin-binding agent.

Aneja R, Liu M, Yates C, Gao J, Dong X, Zhou B, Vangapandu SN, Zhou J, Joshi HC.

Cancer Res. 2008 Mar 1;68(5):1495-503. doi: 10.1158/0008-5472.CAN-07-1874.

37.

Recent patents on proteases and kinases as anti-infective agents: a review.

Vangapandu SN, Aneja R, Chandra R, Joshi HC.

Recent Pat Antiinfect Drug Discov. 2006 Jun;1(2):209-24. Review.

PMID:
18221146
38.

Modulation of multidrug resistance in cancer cells by the E3 ubiquitin ligase seven-in-absentia homologue 1.

Liu M, Aneja R, Wang H, Sun L, Dong X, Huo L, Joshi H, Zhou J.

J Pathol. 2008 Mar;214(4):508-14. doi: 10.1002/path.2312.

PMID:
18213731
39.
40.

PO(2)-dependent differential regulation of multidrug resistance 1 gene expression by the c-Jun NH2-terminal kinase pathway.

Liu M, Li D, Aneja R, Joshi HC, Xie S, Zhang C, Zhou J.

J Biol Chem. 2007 Jun 15;282(24):17581-6. Epub 2007 Apr 23.

41.

p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells.

Aneja R, Ghaleb AM, Zhou J, Yang VW, Joshi HC.

Cancer Res. 2007 Apr 15;67(8):3862-70.

42.

Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.

Aneja R, Dhiman N, Idnani J, Awasthi A, Arora SK, Chandra R, Joshi HC.

Cancer Chemother Pharmacol. 2007 Nov;60(6):831-9. Epub 2007 Feb 7.

PMID:
17285314
43.

Evaluation of two dynamic axial fixators for large ruminants.

Singh GR, Aithal HP, Amarpal, Kinjavdekar P, Maiti SK, Hoque M, Pawde AM, Joshi HC.

Vet Surg. 2007 Jan;36(1):88-97.

PMID:
17214826
44.

In vitro biomechanical properties of linear, circular, and hybrid external skeletal fixation devices for use in large ruminants.

Singh GR, Aithal HP, Saxena RK, Kinjavdekar P, Amarpal, Hoque M, Maiti SK, Pawde AM, Joshi HC.

Vet Surg. 2007 Jan;36(1):80-7.

PMID:
17214825
45.

Synthesis and biological evaluation of a cyclic ether fluorinated noscapine analog.

Aneja R, Vangapandu SN, Joshi HC.

Bioorg Med Chem. 2006 Dec 15;14(24):8352-8. Epub 2006 Sep 27.

PMID:
17008104
46.

Treatment of hormone-refractory breast cancer: apoptosis and regression of human tumors implanted in mice.

Aneja R, Zhou J, Zhou B, Chandra R, Joshi HC.

Mol Cancer Ther. 2006 Sep;5(9):2366-77.

47.

Asymmetric indolylmaleimide derivatives and their complexation with zinc(II)-cyclen.

Kaletas BK, Joshi HC, van der Zwan G, Fanti M, Zerbetto F, Goubitz K, De Cola L, König B, Williams RM.

J Phys Chem A. 2005 Oct 27;109(42):9443-55.

PMID:
16866393
48.

Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.

Aneja R, Vangapandu SN, Lopus M, Viswesarappa VG, Dhiman N, Verma A, Chandra R, Panda D, Joshi HC.

Biochem Pharmacol. 2006 Aug 14;72(4):415-26. Epub 2006 May 10.

PMID:
16780803
49.

Inhibition of the mitotic kinesin Eg5 up-regulates Hsp70 through the phosphatidylinositol 3-kinase/Akt pathway in multiple myeloma cells.

Liu M, Aneja R, Liu C, Sun L, Gao J, Wang H, Dong JT, Sarli V, Giannis A, Joshi HC, Zhou J.

J Biol Chem. 2006 Jun 30;281(26):18090-7. Epub 2006 Apr 20.

50.

Rational design of the microtubule-targeting anti-breast cancer drug EM015.

Aneja R, Lopus M, Zhou J, Vangapandu SN, Ghaleb A, Yao J, Nettles JH, Zhou B, Gupta M, Panda D, Chandra R, Joshi HC.

Cancer Res. 2006 Apr 1;66(7):3782-91.

Supplemental Content

Loading ...
Support Center